Gene: SCNN1A
Official Full Name: sodium channel epithelial 1 subunit alphaprovided by HGNC
Gene Summary: Nonvoltage-gated, amiloride-sensitive, sodium channels control fluid and electrolyte transport across epithelia in many organs. These channels are heteromeric complexes consisting of 3 subunits: alpha, beta, and gamma. This gene encodes the alpha subunit, and mutations in this gene have been associated with pseudohypoaldosteronism type 1 (PHA1), a rare salt wasting disease resulting from target organ unresponsiveness to mineralocorticoids. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO35489 | SCNN1A Knockout cell line (HeLa) | Human | SCNN1A | 1:3~1:6 | Negative | Online Inquiry |
KO35490 | SCNN1A Knockout cell line (HCT 116) | Human | SCNN1A | 1:2~1:4 | Negative | Online Inquiry |
KO35491 | SCNN1A Knockout cell line (A549) | Human | SCNN1A | 1:3~1:4 | Negative | Online Inquiry |
SCNN1A Gene Knockout Cell Lines are highly specialized cell lines engineered to lack the expression of the SCNN1A gene, which encodes for the alpha subunit of the epithelial sodium channel (ENaC). These knockout models serve as a powerful tool for studying ion transport mechanisms, particularly sodium absorption across epithelial tissues, and are of significant importance for understanding various physiological and pathological processes, including hypertension, cystic fibrosis, and other sodium channel-related disorders.
Functionally, these cell lines enable researchers to delineate the biochemical pathways governed by the SCNN1A gene, facilitating investigations into ENaC regulation, signaling pathways, and cellular responses to differing sodium concentrations. The absence of SCNN1A allows for the exploration of compensatory mechanisms activated in response to disrupted sodium homeostasis, thereby providing insights into both basic cellular functions and potential therapeutic targets.
Scientifically, SCNN1A Gene Knockout Cell Lines have wide-ranging applications in research and clinical settings, making them vital for drug screening and the evaluation of new therapeutic strategies aimed at modulating sodium channel activity. Their unique capacity to mimic disease states also enables the investigation of gene therapy approaches and the molecular basis of related disorders.
Compared to traditional cell lines, these knockout models offer significant advantages, including the elimination of confounding variables associated with SCNN1A expression. This specificity enhances the reliability and reproducibility of experimental outcomes, empowering researchers to derive more definitive conclusions from their studies.
For researchers and clinicians seeking to deepen their understanding of sodium channel physiology or implement cutting-edge experimental designs, the SCNN1A Gene Knockout Cell Lines stand out as invaluable resources. Their establishment stems from our commitment to advancing biological research, paired with our expertise in producing robust and reliable biological tools tailored to meet the evolving needs of the scientific community. Our comprehensive product offerings reflect a dedication to supporting innovative research and clinical breakthroughs.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.